{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T07:18:46Z","timestamp":1740122326771,"version":"3.37.3"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,4,21]],"date-time":"2020-04-21T00:00:00Z","timestamp":1587427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,4,21]],"date-time":"2020-04-21T00:00:00Z","timestamp":1587427200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001691","name":"KAKENHI","doi-asserted-by":"crossref","award":["26461077"],"award-info":[{"award-number":["26461077"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Interv Card Electrophysiol"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1007\/s10840-020-00732-y","type":"journal-article","created":{"date-parts":[[2020,4,21]],"date-time":"2020-04-21T05:03:13Z","timestamp":1587445393000},"page":"375-385","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["A randomized comparison of two direct oral anticoagulants for patients undergoing cardiac ablation with a contemporary warfarin control arm"],"prefix":"10.1007","volume":"60","author":[{"given":"Issei","family":"Yoshimoto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhisa","family":"Iriki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoya","family":"Oketani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideki","family":"Okui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hitoshi","family":"Ichiki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryuichi","family":"Maenosono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fuminori","family":"Namino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaaki","family":"Miyata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuru","family":"Ohishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,4,21]]},"reference":[{"key":"732_CR1","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1161\/01.STR.22.8.983","volume":"22","author":"PA Wolf","year":"1991","unstructured":"Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke. 1991;22:983\u20138.","journal-title":"Stroke"},{"key":"732_CR2","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1212\/WNL.28.10.973","volume":"28","author":"PA Wolf","year":"1978","unstructured":"Wolf PA, Dawber TR, Thomas HE Jr, Kannel WB. Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: the Framingham Study. Neurology. 1978;28:973\u20137.","journal-title":"Neurology"},{"key":"732_CR3","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/S0140-6736(09)60443-8","volume":"373","author":"RB Schnabel","year":"2009","unstructured":"Schnabel RB, Sullivan LM, Levy D, Pencina MD, Massaro JM, D\u2019Agostino RB Sr, et al. Development of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort study. Lancet. 2009;373:739\u201345.","journal-title":"Lancet"},{"key":"732_CR4","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/S0002-9343(99)80348-9","volume":"98","author":"AD Krahn","year":"1995","unstructured":"Krahn AD, Manfreda J, Tate RB, Mathewson FA, Cuddy TE. The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study. Am J Med. 1995;98:476\u201384.","journal-title":"Am J Med"},{"key":"732_CR5","doi-asserted-by":"publisher","first-page":"3028","DOI":"10.1161\/01.CIR.99.23.3028","volume":"15","author":"S Levy","year":"1999","unstructured":"Levy S, Maarek M, Coumel P, Guize L, Lekieffre J, Medvedowsky JL, et al. Characterization of different subsets of atrial fibrillation in general practice in France: the ALFA study. The College of French Cardiologists. Circulation. 1999;15:3028\u201335.","journal-title":"Circulation"},{"key":"732_CR6","doi-asserted-by":"publisher","first-page":"297","DOI":"10.7326\/0003-4819-151-5-200909010-00003","volume":"151","author":"DE Singer","year":"2009","unstructured":"Singer DE, Chang Y, Fang MC, Borowsky LH, Pomernacki NK, Udaltsova N, et al. The net clinical benefit of warfarin anticoagulation in atrial fibrillation. Ann Intern Med. 2009;151:297\u2013305.","journal-title":"Ann Intern Med"},{"key":"732_CR7","doi-asserted-by":"publisher","first-page":"857","DOI":"10.7326\/0003-4819-146-12-200706190-00007","volume":"146","author":"RG Hart","year":"2007","unstructured":"Hart RG, Pearce LA, Aguilar MI. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med. 2007;146:857\u201367.","journal-title":"Ann Intern Med"},{"key":"732_CR8","doi-asserted-by":"publisher","first-page":"2638","DOI":"10.1161\/CIRCULATIONAHA.113.006426","volume":"129","author":"L Di Biase","year":"2014","unstructured":"Di Biase L, Burkhardt JD, Santangeli P, Mohanty P, Sanchez JE, Horton R, et al. Periprocedural stroke and bleeding complications in patients undergoing catheter ablation of atrial fibrillation with different anticoagulation management: results from the Role of Coumadin in Preventing Thromboembolism in Atrial Fibrillation (AF) Patients Undergoing Catheter Ablation (COMPARE) randomized trial. Circulation. 2014;129:2638\u201344.","journal-title":"Circulation"},{"key":"732_CR9","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","volume":"361","author":"SJ Connolly","year":"2009","unstructured":"Connolly SJ, Ezekowitz MD, Yusuf S, Eikelboom J, Parekh A, Pogue J, et al. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med. 2009;361:1139\u201351.","journal-title":"N Engl J Med"},{"key":"732_CR10","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1056\/NEJMoa1009638","volume":"365","author":"MR Patel","year":"2011","unstructured":"Patel MR, Mahaffey KW, Gang J, Pan G, Singer DE, Hacke W, et al. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med. 2011;365:883\u201391.","journal-title":"N Engl J Med"},{"key":"732_CR11","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1056\/NEJMoa1107039","volume":"365","author":"CB Granger","year":"2011","unstructured":"Granger CB, Alexander JH, McMurray JJ, Lopes RD, Hylek EM, Hanna M, et al. Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med. 2011;365:981\u201392.","journal-title":"N Engl J Med"},{"key":"732_CR12","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1056\/NEJM199809033391003","volume":"339","author":"M Ha\u00efssaguerre","year":"1998","unstructured":"Ha\u00efssaguerre M, Ja\u00efs P, Shah DC, Takahashi A, Hocini M, Quiniou G, et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med. 1998;339:659\u201366.","journal-title":"N Engl J Med"},{"key":"732_CR13","doi-asserted-by":"publisher","first-page":"2634","DOI":"10.1001\/jama.293.21.2634","volume":"293","author":"OM Wazni","year":"2005","unstructured":"Wazni OM, Marrouche NF, Martin DO, Verma A, Bhargava M, Saliba W, et al. Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation: a randomized trial. JAMA. 2005;293:2634\u201340.","journal-title":"JAMA"},{"key":"732_CR14","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/S0735-1097(03)00577-1","volume":"42","author":"C Pappone","year":"2003","unstructured":"Pappone C, Rosanio S, Augello G, Gallus G, Vicedomini G, Mazzone P, et al. Mortality, morbidity, and quality of life after circumferential pulmonary vein ablation for atrial fibrillation: outcomes from a controlled nonrandomized long-term study. J Am Coll Cardiol. 2003;42:185\u201397.","journal-title":"J Am Coll Cardiol"},{"key":"732_CR15","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1161\/01.CIR.0000157153.30978.67","volume":"111","author":"R Cappato","year":"2005","unstructured":"Cappato R, Calkins H, Chen SA, Davies W, Iesaka Y, Kalman J, et al. Worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circulation. 2005;111:1100\u20135.","journal-title":"Circulation"},{"key":"732_CR16","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1093\/eurheartj\/ehi583","volume":"27","author":"G Stabile","year":"2006","unstructured":"Stabile G, Bertaglia E, Senatore G, De Simone A, Zoppo F, Donnici G, et al. Catheter ablation treatment in patients with drug-refractory atrial fibrillation: a prospective, multi-centre, randomized, controlled study (Catheter Ablation For The Cure Of Atrial Fibrillation Study). Eur Heart J. 2006;27:216\u201321.","journal-title":"Eur Heart J"},{"key":"732_CR17","doi-asserted-by":"publisher","first-page":"2606","DOI":"10.1161\/CIRCULATIONAHA.107.691386","volume":"115","author":"H Oral","year":"2007","unstructured":"Oral H, Chugh A, Good E, Wimmer A, Dey S, Gadeela N, et al. Radiofrequency catheter ablation of chronic atrial fibrillation guided by complex electrograms. Circulation. 2007;115:2606\u201312.","journal-title":"Circulation"},{"key":"732_CR18","doi-asserted-by":"publisher","first-page":"2044","DOI":"10.1016\/j.jacc.2003.12.054","volume":"43","author":"K Nademanee","year":"2004","unstructured":"Nademanee K, McKenzie J, Kosar E, Schwab M, Sunsaneewitayakul B, Vasavakul T, et al. A new approach for catheter ablation of atrial fibrillation: mapping of electrophysiologic substrate. J Am Coll Cardiol. 2004;43:2044\u201353.","journal-title":"J Am Coll Cardiol"},{"key":"732_CR19","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1161\/CIRCULATIONAHA.110.937953","volume":"122","author":"F Gaita","year":"2010","unstructured":"Gaita F, Caponi D, Pianelli M, Scaglione M, Toso E, Cesarani F, et al. Radiofrequency catheter ablation of atrial fibrillation: a cause of silent thromboembolism? Magnetic resonance imaging assessment of cerebral thromboembolism in patients undergoing ablation of atrial fibrillation. Circulation. 2010;122:1667\u201373.","journal-title":"Circulation"},{"key":"732_CR20","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1111\/j.1540-8167.2009.01540.x","volume":"20","author":"D Scherr","year":"2009","unstructured":"Scherr D, Sharma K, Dalal D, Spragg D, Chilukuri K, Cheng A, et al. Incidence and predictors of periprocedural cerebrovascular accident in patients undergoing catheter ablation of atrial fibrillation. J Cardiovasc Electrophysiol. 2009;20:1357\u201363.","journal-title":"J Cardiovasc Electrophysiol"},{"key":"732_CR21","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1093\/europace\/eup350","volume":"12","author":"JW Schrickel","year":"2010","unstructured":"Schrickel JW, Lickfett L, Lewalter T, Mittman-Braun E, Selbach S, Strach K, et al. Incidence and predictors of silent cerebral embolism during pulmonary vein catheter ablation for atrial fibrillation. Europace. 2010;12:52\u20137.","journal-title":"Europace"},{"key":"732_CR22","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/j.1540-8167.2005.00337.x","volume":"17","author":"SJ Asirvatham","year":"2006","unstructured":"Asirvatham SJ, Friedman PA. Silent cerebral thromboembolism with left atrial ablation: a lurking danger. J Cardiovasc Electrophysiol. 2006;17:8\u201310.","journal-title":"J Cardiovasc Electrophysiol"},{"key":"732_CR23","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1046\/j.1540-8167.2002.00764.x","volume":"13","author":"LC Kok","year":"2002","unstructured":"Kok LC, Mangrum JM, Haines DE, Mounsey JP. Cerebrovascular complication associated with pulmonary vein ablation. J Cardiovasc Electrophysiol. 2002;13:764\u20137.","journal-title":"J Cardiovasc Electrophysiol"},{"key":"732_CR24","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1111\/j.1540-8167.2011.02259.x","volume":"23","author":"H Ichiki","year":"2012","unstructured":"Ichiki H, Oketani N, Ishida S, Iriki Y, Okui H, Maenosono R, et al. Incidence of asymptomatic cerebral microthromboembolism after atrial fibrillation ablation guided by complex fractionated atrial electrogram. J Cardiovasc Electrophysiol. 2012;23:567\u201373.","journal-title":"J Cardiovasc Electrophysiol"},{"key":"732_CR25","doi-asserted-by":"publisher","first-page":"2550","DOI":"10.1161\/CIRCULATIONAHA.109.921320","volume":"121","author":"L Di Biase","year":"2010","unstructured":"Di Biase L, Burkhardt JD, Mohanty P, Sanchez J, Horton R, Gallinghouse GJ, et al. Periprocedural stroke and management of major bleeding complications in patients undergoing catheter ablation of atrial fibrillation: the impact of periprocedural therapeutic international normalized ratio. Circulation. 2010;121:2550\u20136.","journal-title":"Circulation"},{"key":"732_CR26","doi-asserted-by":"publisher","first-page":"e69","DOI":"10.1016\/j.thromres.2009.11.031","volume":"126","author":"SR Vazquez","year":"2010","unstructured":"Vazquez SR, Johnson SA, Rondina MT. Peri-procedural anticoagulation in patients undergoing ablation for atrial fibrillation. Thromb Res. 2010;126:e69\u201377.","journal-title":"Thromb Res"},{"key":"732_CR27","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1016\/j.hrthm.2009.07.007","volume":"6","author":"AA Hussein","year":"2009","unstructured":"Hussein AA, Martin DO, Saliba W, Patel D, Karim S, Batal O, et al. Radiofrequency ablation of atrial fibrillation under therapeutic international normalized ratio: a safe and efficacious peri- procedural anticoagulation strategy. Heart Rhythm. 2009;6:1425\u20139.","journal-title":"Heart Rhythm"},{"key":"732_CR28","doi-asserted-by":"publisher","first-page":"2531","DOI":"10.1161\/CIRCULATIONAHA.107.727784","volume":"116","author":"OM Wazni","year":"2007","unstructured":"Wazni OM, Beheiry S, Fahmy T, Barrett C, Hao S, Patel D, et al. Atrial fibrillation ablation in patients with therapeutic international normalized ratio: comparison of strategies of anticoagulation management in the periprocedural period. Circulation. 2007;116:2531\u20134.","journal-title":"Circulation"},{"key":"732_CR29","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.jjcc.2016.03.014","volume":"69","author":"A Yoshimura","year":"2017","unstructured":"Yoshimura A, Iriki Y, Ichiki H, Oketani N, Okui H, Maenosono R, et al. Evaluation of safety and efficacy of periprocedural use of rivaroxaban and apixaban in catheter ablation for atrial fibrillation. J Cardiol. 2017;69:228\u201335.","journal-title":"J Cardiol"},{"key":"732_CR30","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1111\/pace.12195","volume":"36","author":"H Ichiki","year":"2013","unstructured":"Ichiki H, Oketani N, Ishida S, Iriki Y, Okui H, Maenosono R, et al. The incidence of asymptomatic cerebral microthromboembolism after atrial fibrillation ablation: comparison of warfarin and dabigatran. Pacing Clin Electrophysiol. 2013;36:1328\u201335.","journal-title":"Pacing Clin Electrophysiol"},{"key":"732_CR31","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1161\/CIRCEP.113.000320","volume":"6","author":"M Bassiouny","year":"2013","unstructured":"Bassiouny M, Saliba W, Rickard J, Shao M, Sey A, Diab M, et al. Use of dabigatran for periprocedural anticoagulation in patients undergoing catheter ablation for atrial fibrillation. Circ Arrhythm Electrophysiol. 2013;6:460\u20136.","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"732_CR32","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s10840-012-9708-z","volume":"35","author":"D Snipelisky","year":"2012","unstructured":"Snipelisky D, Kauffman C, Prussak K, Johns G, Venkatachalam K, Kusumoto F. A comparison of bleeding complications post-ablation between warfarin and dabigatran. J Interv Card Electrophysiol. 2012;35:29\u201333.","journal-title":"J Interv Card Electrophysiol"},{"key":"732_CR33","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1136\/heartjnl-2013-304386","volume":"100","author":"R Providencia","year":"2014","unstructured":"Providencia R, Albenque JP, Combes S, Bouzeman A, Casteigt B, Combes N, et al. Safety and efficacy of dabigatran versus warfarin in patients undergoing catheter ablation of atrial fibrillation: a systematic review and meta-analysis. Heart. 2014;100:324\u201335.","journal-title":"Heart"},{"key":"732_CR34","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.joa.2014.04.006","volume":"31","author":"F Namino","year":"2015","unstructured":"Namino F, Iriki Y, Maenosono R, Ichiki H, Okui H, Yoshimura A, et al. The optimal setting of complex fractionated atrial electrogram software in substrate ablation for atrial fibrillation. J Arrhythmia. 2015;31:6\u201311.","journal-title":"J Arrhythmia"},{"key":"732_CR35","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.jjcc.2012.02.009","volume":"60","author":"R Maenosono","year":"2012","unstructured":"Maenosono R, Oketani N, Ishida S, Iriki Y, Ichiki H, Okui H, et al. Effectiveness of esophagus detection by three-dimensional electroanatomical mapping to avoid esophageal injury during ablation of atrial fibrillation. J Cardiol. 2012;60:119\u201325.","journal-title":"J Cardiol"},{"key":"732_CR36","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.joa.2012.05.011","volume":"28","author":"N Oketani","year":"2012","unstructured":"Oketani N, Ichiki H, Iriki Y, Okui H, Maenosono R, Namino F, et al. Catheter ablation of atrial fibrillation guided by complex fractionated atrial electrogram mapping with or without pulmonary vein isolation. J Arrhythmia. 2012;28:311\u201323.","journal-title":"J Arrhythmia"},{"key":"732_CR37","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1212\/WNL.0b013e3181e7c9dd","volume":"75","author":"PD Schellinger","year":"2010","unstructured":"Schellinger PD, Bryan RN, Caplan LR, Detre JA, Edelman RR, Jaigobin C, et al. Evidence based guideline: the role of diffusion and perfusion MRI for the diagnosis of acute ischemic stroke: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology. 2010;75:177\u201385.","journal-title":"Neurology"},{"key":"732_CR38","doi-asserted-by":"crossref","unstructured":"Gaita F, Leclercq JF, Schunmacher B, Scaglione M, Toso E, Halimi F, et al. Incidence of silent cerebral thromboembolic lesions after atrial fibrillation ablation may change according to technology used: comparison of irrigated radiofrequency, multipolar nonirrigated catheter and cryobaloon. J Cardiovasc Electrophysiol. 2011; in press.","DOI":"10.1111\/j.1540-8167.2011.02050.x"}],"container-title":["Journal of Interventional Cardiac Electrophysiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10840-020-00732-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10840-020-00732-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10840-020-00732-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T07:59:35Z","timestamp":1621497575000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10840-020-00732-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,21]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["732"],"URL":"https:\/\/doi.org\/10.1007\/s10840-020-00732-y","relation":{},"ISSN":["1383-875X","1572-8595"],"issn-type":[{"type":"print","value":"1383-875X"},{"type":"electronic","value":"1572-8595"}],"subject":[],"published":{"date-parts":[[2020,4,21]]},"assertion":[{"value":"17 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All patients provided written informed consent to participate in this study, and the study protocol was approved by the institutional ethics committee of Kagoshima University Hospital.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that there are no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}